<unk>  is an autoimmune demyelinating disease of the central nervous system and it’s known to be multi-factorial. The onset of symptoms are mostly between the age of fifteen to forty years (rarely before age fifteen or after age sixty), and include fatigue, mood problems, spasticity, bowel and bladder dysfunction, cognitive impairment, eye movement problems, heat sensitivity, incoordination, pain, sexual dysfunction, sleep disorder, vertigo and visual loss. There is no single diagnostic study of choice for<unk> . Diagnosis is currently made by the fulfilment of the McDonald criteria, which include clinical presentation, cerebral plaques on MRI , and oligoclonal bands in CSF analysis. Treatment for<unk>  includes disease-modifying medications (DMTs) and immunosuppressors to prevent relapses and Glucocorticoid therapy in acute exacerbations.
Multiple sclerosis
Paraneoplastic cerebellar degeneration
Amyotrophic lateral sclerosis
Idiopathic inflammatory demyelinating diseases
Multiple system atrophy
Acute disseminated encephalomyelitis
Central pontine myelinolysis
Chronic inflammatory demyelinating polyneuropathy